[HTML][HTML] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
…, J Latella, YY Leung, C Lindsay, E Lubrano… - Nature Reviews …, 2022 - nature.com
Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients
E Lubrano, C Ciacci, PRJ Ames, G Mazzacca… - …, 1996 - academic.oup.com
Arthritis has often been alluded to as an extra-intestinal clinical manifestation of coeliac
disease, but definitive data regarding its prevalence are still lacking. We therefore evaluated the …
disease, but definitive data regarding its prevalence are still lacking. We therefore evaluated the …
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid …
…, RD Grembiale, V Liakouli, R Lories, E Lubrano… - Autoimmunity …, 2017 - Elsevier
Autoimmune diseases are a complex set of diseases characterized by immune system
activation and, although many progresses have been done in the last 15 years, several unmet …
activation and, although many progresses have been done in the last 15 years, several unmet …
Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis
…, ME Husni, TJ Love, E Lubrano… - Arthritis & …, 2016 - Wiley Online Library
Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …
Consensus on a core set of domains for psoriatic arthritis.
…, D Van Der Heijde, E Husni, E Lubrano… - The Journal of …, 2007 - jrheum.org
A psoriatic arthritis (PsA) module was convened at OMERACT 8 in order to achieve
consensus on the core domains that should be included in randomized controlled trials and …
consensus on the core domains that should be included in randomized controlled trials and …
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
…, P Healy, EM Kerzberg, YJ Lee, E Lubrano… - Annals of the …, 2013 - ard.bmj.com
… Ennio Lubrano20, … This web only file has been produced by the BMJ Publishing Group
from an electronic file supplied by the author(s) and has not been edited for content. …
from an electronic file supplied by the author(s) and has not been edited for content. …
Drug-induced lupus erythematosus.
P Sarzi-Puttini, F Atzeni, F Capsoni, E Lubrano… - …, 2005 - search.ebscohost.com
… [44] Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced
autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996;312: 169–172. …
autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996;312: 169–172. …
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study
…, C Salvarani, JR Kalden, E Lubrano… - The Journal of …, 2011 - jrheum.org
Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …
Outcome measures in psoriatic arthritis.
…, PS Helliwell, O Fitzgerald, A Cauli, E Lubrano… - The Journal of …, 2007 - jrheum.org
Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually
seronegative for rheumatoid factor, has emerged as a more common and severe disease than …
seronegative for rheumatoid factor, has emerged as a more common and severe disease than …
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
Background The objective was to compare different definitions of remission and low disease
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients’ and physicians…
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients’ and physicians…